Background Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed
to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute …

Background Studies report hypercoagulability in coronavirus disease 2019 (COVID‐19),
leading many institutions to escalate anticoagulation intensity for thrombosis prophylaxis …

Background Because of the high risk of thrombotic complications (TCs) during SARS-CoV-2
infection, several scientific societies have proposed to increase the dose of preventive …

COVID-19 infection causes respiratory pathology with severe interstitial pneumonia and
extra-pulmonary complications; in particular, it may predispose to thromboembolic disease …

Simple Summary The aims of this study are:(1) to analyze the risk of vein thrombosis and
pulmonary embolism in patients affected by pneumonia due to Covid-19;(2) to evaluate …

Introduction We recently reported a high cumulative incidence of thrombotic complications in
critically ill patients with COVID-19 admitted to the intensive care units (ICUs) of three Dutch …

Background There is no current standardized approach to anticoagulation in patients with
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study …

Introduction One of the most prominent and concerning complications associated with
coronavirus disease 2019 (COVID-19) is venous and arterial thromboembolisms. The aim of …

Objective To evaluate differences in morbidity and mortality among mechanically ventilated
patients with COVID-19 treated with therapeutic versus prophylactic anticoagulation …

Covid-19 has affected 16Millions people worldwide with 644 K death as of July 26th, 2020. It
is associated with inflammation and microvascular thrombosis—anticoagulation in widely …